Tanaka Nobumichi, Asakawa Isao, Nakai Yasushi, Miyake Makito, Anai Satoshi, Yamaki Kaori, Fujii Tomomi, Hasegawa Masatoshi, Fujimoto Kiyohide
Department of, Departments of, Urology, Nara Medical University, Kashihara, Nara, Japan.
Department of, Radiation Oncology, Nara Medical University, Kashihara, Nara, Japan.
Int J Urol. 2020 Nov;27(11):1013-1017. doi: 10.1111/iju.14349. Epub 2020 Aug 11.
To compare the dose evaluation parameters between conventional (using loose seed alone) and hybrid (using loose seeds in combination with stranded seeds) low-dose rate brachytherapy for prostate cancer.
Between 2014 and July 2016, a total of 219 patients who underwent low-dose rate brachytherapy were enrolled in a randomized controlled trial (trial number: UMIN 000012780). Patients were randomized and allocated to two groups (conventional method vs hybrid method). Post-dosimetric parameters (%D90, minimal percentage of the dose received by 90% of the prostate gland; V100, percentage of the prostate volume receiving 100% of the prescribed minimal peripheral dose; V150, percentage of the prostate volume receiving 150% of the prescribed minimal peripheral dose; %UD30, minimal percentage of the dose received by 30% of the urethra; R100, rectal volume [mL] receiving 100% of the prescribed dose) calculated at 1 month after seed implantation by computed tomography scan were compared between the two groups, as well as the post-dosimetric parameters using the planning target volume of the prostate + 5-mm margin.
Regarding dose evaluation parameters, the prostate dose (%D90, V100, V150) and the urethral dose (%UD30) were not significantly different between the two groups, whereas V100 (+5-mm margin) and %D90 (+5-mm margin) were significantly higher in the hybrid method group compared with the conventional method group (P < 0.001).
The present randomized study shows that the hybrid method of low-dose rate brachytherapy can achieve a higher coverage of the periprostatic region compared with the conventional method while maintaining an acceptable level of urethral and rectal doses.
比较传统(仅使用松散种子源)和混合(松散种子源与串珠状种子源联合使用)低剂量率近距离放射治疗前列腺癌时的剂量评估参数。
2014年至2016年7月期间,共有219例行低剂量率近距离放射治疗的患者被纳入一项随机对照试验(试验编号:UMIN 000012780)。患者被随机分为两组(传统方法组与混合方法组)。通过计算机断层扫描计算种子植入后1个月时的剂量学参数(%D90,即前列腺90%体积所接受剂量的最小百分比;V100,接受规定最小周边剂量100%的前列腺体积百分比;V150,接受规定最小周边剂量150%的前列腺体积百分比;%UD30,尿道30%体积所接受剂量的最小百分比;R100,接受规定剂量100%的直肠体积[mL]),并在两组之间进行比较,同时也比较了使用前列腺+5 mm边界的计划靶体积时的剂量学参数。
关于剂量评估参数,两组之间前列腺剂量(%D90、V100、V150)和尿道剂量(%UD30)无显著差异,而混合方法组的V100(+5 mm边界)和%D90(+5 mm边界)显著高于传统方法组(P < 0.001)。
本随机研究表明,与传统方法相比,低剂量率近距离放射治疗的混合方法在保持尿道和直肠剂量可接受水平的同时,能实现对前列腺周围区域更高的覆盖。